Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05256069 · ClinicalTrials.gov registry record · Early Phase 1
Sex-related Differences in Sympathetic Vascular Transduction in the Setting of Hypoxemia
A Early Phase 1 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 31
- Enrollment target
NCT05256069 is a Early Phase 1 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 31 participants.
The verdict
NCT05256069, a Early Phase 1 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this project is to identify sex-related differences in the effect of hypoxia on sympathetic vascular transduction.
Interventions
- DRUG Placebo
- DRUG Propranolol Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2025-07-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05256069
The ClinicalTrials.gov registry entry for NCT05256069 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05256069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05256069 about?
NCT05256069 is a clinical study titled "Sex-related Differences in Sympathetic Vascular Transduction in the Setting of Hypoxemia". The purpose of this project is to identify sex-related differences in the effect of hypoxia on sympathetic vascular transduction.
What is the current status of trial NCT05256069?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 31 participants. The study started on 2023-04-26. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT05256069?
The interventions under investigation include: Placebo (DRUG), Propranolol Pill (DRUG).
Who is sponsoring clinical trial NCT05256069?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.